FOXA1 Reprogramming Dictates Retinoid X Receptor Response in ESR1-Mutant Breast Cancer.
Wu Y, Li Z, Wedn AM, Casey AN, Brown D, Rao SV, Omarjee S, Hooda J, Carroll JS, Gertz J, Atkinson JM, Lee AV, Oesterreich S.
Wu Y, et al. Among authors: gertz j.
Mol Cancer Res. 2023 Jun 1;21(6):591-604. doi: 10.1158/1541-7786.MCR-22-0516.
Mol Cancer Res. 2023.
PMID: 36930833
Free PMC article.